Madhulina Maity

Madhulina Maity

Auto-generated profile, based on publicly available information

Madhulina Maity

Drug Discovery and Development Division, Ex- Research Scientist, Patanjali Research Institute, Hardwar, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
RSRakesh Sarkar
Rakesh Sarkar
SMSuvrotoa Mitra
Suvrotoa Mitra
PCPritam Chandra
Pritam Chandra
PSPriyanka Saha
Priyanka Saha
ABAnindita Banerjee
Anindita Banerjee
MSMamta Chawla Sarkar
Mamta Chawla Sarkar
Accumulation of mutations within the genome is the primary driving force for viral evolution within an endemic setting. This inherent feature often leads to altered virulence, infectivity and transmissibility as well as antigenic shift to escape host immunity, which might compromise the efficacy of vaccines and antiviral drugs. Therefore, we aimed at genome-wide analyses of circulating SARS-CoV-2 viruses for the emergence of novel co-existing mutations and trace their spatial distribution within India. Comprehensive analysis of whole genome sequences of 441 Indian SARS-CoV-2 strains revealed the occurrence of 33 different mutations, 21 being distinctive to India. Emergence of novel mutations were observed in S glycoprotein (7/33), NSP3 (6/33), RdRp/NSP12 (4/33), NSP2 (2/33) and N (2/33). Non-synonymous mutations were found to be 3.4 times more prevalent than synonymous mutations. We classified the Indian isolates into 22 groups based on the co-existing mutations. Phylogenetic analyses revealed that representative strain of each group divided themselves into various sub-clades within their respective clades, based on the presence of unique co-existing mutations. India was dominated by A2a clade (55.60%) followed by A3 (37.38%) and B (7%), but exhibited heterogeneous distribution among various geographical regions. The A2a clade mostly predominated in East India, Western India and Central India, whereas A3 clade prevailed in South and North India. In conclusion, this study highlights the divergent evolution of SARS-CoV-2 strains and co-circulation of multiple clades in India. Monitoring of the emerging mutations would pave ways for vaccine formulation and designing of antiviral drugs.

20 December 2025 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
ASAvipsha Sarkar
Avipsha Sarkar
ARAnirban Roy
Anirban Roy
TGTanusree Ghorai
Tanusree Ghorai
BBBijita Bhowmick
Bijita Bhowmick
MMMadhulina Maity
Madhulina Maity
SDSATADAL DAS
SATADAL DAS